Key facts
- It has raised $13.2M; the latest was Later Stage VC in Oct 2024.
- Notable investors include Innovation Authority, Intellectual Ventures, ALIVE Israel Healthtech Fund, BayMed Venture Partners, Boston Scientific — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Append Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Append Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Append Medical
Developer of a transcatheter Left Atrial Appendage (LAA) elimination system designed to prevent stroke by removing the LAA cavity. The company's system eliminates the LAA through tissue invagination and suture-based closure as an alternative to implant-based approaches, enabling healthcare providers to reduce device-related thromboembolism risk by leaving minimal foreign material at the closure site.
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2016
- Employees
- 20
- Website
- appendmedical.com/
- Ownership
- Privately Held (backing)
Append Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Append Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Append Medical in its N-PORT filings yet. We sweep new filings monthly.